Heidi Demaegdt

Evaluation of a Screening System for Obesogenic Compounds: Screening of Endocrine Disrupting Compounds and Evaluation of the PPAR Dependency of the Effect

Anna Pereira-Fernandes, Heidi Demaegdt, K. Vandermeiren et al. · PLoS ONE · 2013 · 182 citations · Full text

Lipid Analysis, Ppar Dependency, Screening System +27

Angiotensin IV Activates the Nuclear Transcription Factor-κB and Related Proinflammatory Genes in Vascular Smooth Muscle Cells

Vanesa Esteban, Mónica Rupérez, Elsa Sánchez‐López et al. · Circulation Research · 2005 · 97 citations · Full text

Immunology, Ang Ii, Inflammatory Response Regulation +22

Disulfide Cyclized Tripeptide Analogues of Angiotensin IV as Potent and Selective Inhibitors of Insulin-Regulated Aminopeptidase (IRAP)

Hanna Andersson, Heidi Demaegdt, Georges Vauquelin et al. · Journal of Medicinal Chemistry · 2010 · 67 citations · Full text

Pressor and Renal Hemodynamic Effects of the Novel Angiotensin A Peptide Are Angiotensin II Type 1A Receptor Dependent

Rui Yang, Ilse Smolders, Patrick Vanderheyden et al. · Hypertension · 2011 · 55 citations

Potent Macrocyclic Inhibitors of Insulin-Regulated Aminopeptidase (IRAP) by Olefin Ring-Closing Metathesis

Hanna Andersson, Heidi Demaegdt, Anders Johnsson et al. · Journal of Medicinal Chemistry · 2011 · 47 citations · Full text

Potent Macrocyclic Inhibitors, Peptide Science, Peptide Therapeutics +18